Physician profile
Ryan Matthew Johnson
NPI 1851970693
$718.12
in general payments reported to CMS, 2019-2025
7 companies · $329 in 2025
The $329 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.13 · 2022: $12.55 · 2023: $51.87 · 2024: $305 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380 · Education: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.44 |
| Education | $305.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $325.13 | 2021-2024 | |
| Avita Medical Americas, LLC | $112.73 | 2025 | Permeaderm, Recell, Cohealyx |
| Urgo Medical North America, LLC | $97.47 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Ethicon US, LLC | $60.35 | 2025 | Harmonic, Enseal X1, Echelon Flex |
| Davol INC. | $58.02 | 2025 | Phasix Mesh |
| Nuvasive, INC. | $51.87 | 2023 | Reline |
| Lemaitre Vascular, INC. | $12.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.